PDMR Dealing
August 21 2017 - 5:34AM
Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a
clinical-stage biopharmaceutical company focused on developing and
commercializing innovative therapies for respiratory diseases,
announces that, on August 17, 2017, Dr. David Ebsworth,
Non-Executive Chairman of the Company, purchased 8,130 ordinary
shares of 5 pence each in the Company (the “Ordinary Shares”) at a
price of 122.5 pence per Ordinary Share. Following the
acquisition, Dr. Ebsworth will have an interest in the Company of
125,787 Ordinary Shares, representing 0.12% of the Company’s issued
share capital.
The notification of dealing form can be found
below.
For further information, please contact:
Verona Pharma plc |
Tel:
+44 (0)20 3283 4200 |
Jan-Anders Karlsson, Chief Executive Officer |
info@veronapharma.com |
|
|
N+1
Singer (Nominated Adviser and UK Broker) |
Tel:
+44 (0)20 7496 3000 |
Aubrey Powell / James White |
|
|
|
FTI
Consulting (UK Media and Investor enquiries) |
Tel:
+44 (0)20 3727 1000 |
Simon
Conway / Natalie Garland-Collins |
veronapharma@fticonsulting.com |
|
|
ICR,
Inc. (US Media and Investor enquiries) |
|
Darcie
Robinson |
Tel:
+1 203-682-8379Darcie.Robinson@icrinc.com |
Stephanie Carrington |
Tel.
+1 646-277-1282Stephanie.Carrington@icrinc.com |
1 |
Details of the person discharging managerial
responsibilities/person closely associated |
a) |
Name |
David Ebsworth |
2 |
Reason for the notification |
a) |
Position/status |
Non-Executive Chairman |
b) |
Initial notification/Amendment |
Initial notification |
3 |
Details of the issuer, emission allowance market
participant, auction platform, auctioneer or auction monitor |
a) |
Name |
Verona Pharma plc |
b) |
LEI |
213800EVI6O6J3TIAL06 |
4 |
Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have been
conducted |
a) |
Description of the financial instrument, type of instrument |
Ordinary Shares of 5 pence each |
Identification code |
GB00BYW2KH80 |
b) |
Nature of the transaction |
David Ebsworth purchased 8,130 Ordinary Shares |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
122.5 pence per Ordinary Share |
8,130 Ordinary Shares |
|
d) |
Aggregated information |
N/A |
- Aggregated volume |
- Price |
|
e) |
Date of the transaction |
17 August 2017 |
f) |
Place of the transaction |
London Stock Exchange, AIM |
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Apr 2024 to May 2024
Verona Pharma (LSE:VRP)
Historical Stock Chart
From May 2023 to May 2024